About the format
Two plenary sessions frame the conference: the opening plenary on the first afternoon and the second plenary on the morning of day two, where the Swiss Biotech Report is launched and the Swiss Biotech Success Stories Award is presented.
The opening plenary sets the theme of the year. In 2026, Kaspar Sutter welcomed the conference on behalf of the Canton of Basel-Stadt, Michael Altorfer opened for the Swiss Biotech Association, and Roche CEO Thomas Schinecker joined Swiss Biotech Association President Patrick Amstutz for a fireside session, followed by a business development panel and Swissmedic.
The second plenary belongs to the ecosystem: a keynote panel on the state of Swiss biotech, the launch of the Swiss Biotech Report with EY, the Swiss Biotech Success Stories Award and an investor panel with cross-Atlantic perspectives on Swiss biotech.

Why take part
Fireside sessions with the leaders shaping the Swiss and global industry.
The definitive annual review of the Swiss biotech industry, presented live.
The Swiss Biotech Association honors a career of sustainable contribution to the industry.
Last edition
Both plenaries were moderated by Monika Jones.
Monday, 12:45
Fireside session: Thomas Schinecker, CEO Roche Group, with Patrick Amstutz
Plenary I
Monday, 13:20
Business development panel with Cooley, Centerview, BeOne Medicines and Araris
Plenary I
Monday, 13:45
Swissmedic: Vincenza Trivigno, Executive Director
Plenary I
Tuesday, 10:10
Keynote panel on the Swiss biotech ecosystem with Versant Ventures, Windward Bio, Roche pRED and Omega Ventures
Plenary II
Tuesday, 10:55
Swiss Biotech Report 2026 with EY
Plenary II
Tuesday, 11:25
Investor panel: cross-Atlantic perspectives with Bain Capital, Vianti Capital and Novo Ventures
Plenary II
The plenary sessions are not streamed or recorded. Register to attend in person.
Program